SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,459,560 | +109.4% | 16,050 | -51.0% | 6.34% | +90.5% |
| Q1 2023 | $4,516,689 | -48.4% | 32,770 | -51.5% | 3.33% | -38.2% |
| Q4 2022 | $8,746,650 | +90.7% | 67,500 | +62.7% | 5.38% | +172.6% |
| Q3 2022 | $4,587,000 | -42.2% | 41,500 | -30.8% | 1.98% | +39.9% |
| Q2 2018 | $7,931,000 | +478.1% | 60,000 | +20.0% | 1.41% | +176.9% |
| Q4 2016 | $1,372,000 | -75.1% | 50,000 | -44.3% | 0.51% | -75.3% |
| Q3 2016 | $5,509,000 | +37.6% | 89,700 | -57.3% | 2.07% | +7.5% |
| Q2 2016 | $4,005,000 | +38.4% | 210,000 | +180.0% | 1.92% | +39.0% |
| Q4 2015 | $2,894,000 | +184.0% | 75,000 | +136.3% | 1.38% | +134.6% |
| Q3 2015 | $1,019,000 | – | 31,744 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |